WallStreetZenWallStreetZen

NASDAQ: PRQR
Proqr Therapeutics Nv Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Proqr Therapeutics Nv revenue was $22.30M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $5.2M, up 11.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRQR annual revenue was $20.4M, with 92.4% growth year-over-year.

PRQR past revenue growth

How has PRQR's revenue growth performed historically?

Company
45.51%
Industry
1,675.38%
Market
37.92%
PRQR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PRQR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PRQR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PRQR revenue history

Current Revenue
$21.3M
Current Earnings
-$32.8M
Current Profit Margin
-153.8%

Be the first to know when PRQR announces revenue.

PRQR Revenue History By Year

PRQR Yearly RevenuePRQR RevenuePRQR ChangePRQR Revenue Growth
2024-12-31$20.36M$9.78M+92.37%
2023-12-31$10.58M$5.95M+128.23%
2022-12-31$4.64M$1.93M+71.61%
2021-12-31$2.70M-$8.82M-76.56%
2020-12-31$11.53M$9.35M+430.72%
2019-12-31$2.17M-$4.45M-67.20%
2018-12-31$6.62M$4.83M+268.96%
2017-12-31$1.79M-$129.49k-6.73%
2016-12-31$1.92M-$1.59M-45.22%
2015-12-31$3.51M$3.13M+826.94%
2014-12-31$378.93k$219.38k+137.49%
2013-12-31$159.56kN/AN/A

1 of 1

Proqr Therapeutics Nv Revenue FAQ

What was PRQR's revenue last quarter?

On Invalid Date, Proqr Therapeutics Nv (NASDAQ: PRQR) reported Q1 2025 revenue of $5.15 million up 1.74% year over year. In the same quarter last year, Proqr Therapeutics Nv's revenue was $5.07 million.

What was Proqr Therapeutics Nv's revenue in 2024?

Proqr Therapeutics Nv's annual revenue for the twelve months ending Dec 31, 2024 was $20.36 million, a 92.37% increase year over year.

How much does Proqr Therapeutics Nv make in a day?

Based on Proqr Therapeutics Nv annual revenue for the past five years, PRQR makes an average of $27,292.63 per day.

What was Proqr Therapeutics Nv's annual revenue growth in the past year?

As of Q3 2025, Proqr Therapeutics Nv's revenue has grown 45.51% year over year. This is 1,629.88 percentage points lower than the US Biotechnology industry revenue growth rate of 1,675.38%. Proqr Therapeutics Nv's revenue in the past year totaled $22.30 million.

How much does Proqr Therapeutics Nv make in a year?

Proqr Therapeutics Nv's revenue by year for the past five years is:
  • Proqr Therapeutics Nv's revenue for the twelve months ending Dec 31, 2024 was $20.36 million, a 92.37% increase year over year.
  • Proqr Therapeutics Nv's annual revenue for Dec 31, 2023 was $10.58 million, a 128.23% increase from 2022.
  • Proqr Therapeutics Nv's annual revenue for 2022 was $4.64 million, a 71.61% increase from 2021.
  • Proqr Therapeutics Nv's annual revenue for 2021 was $2.70 million, a 76.56% decrease from 2020.
  • Proqr Therapeutics Nv's annual revenue for 2020 was $11.53 million, a 430.72% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.